Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline in Patients with Inadequate Response to Escitalopram
NCT00179257Phase 3Completed
- Sponsor
- Vanderbilt University
- Start
- Jun 2004
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of sertraline in major depressive disorder (MDD), sponsored by Vanderbilt University. Primary endpoints: Quality of Life, Enjoyment, and Satisfaction Scale at 8 weeks, Hamilton Rating Scale for Depression (21-item) at 8 weeks and 1 more. Started Jun 2004; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00179257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179257.